Clinical Trials
5
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
The Plenaxis® Experience Study
- Conditions
- Prostate Cancer
- First Posted Date
- 2005-02-14
- Last Posted Date
- 2006-09-19
- Lead Sponsor
- PRAECIS Pharmaceuticals Inc.
- Target Recruit Count
- 2000
- Registration Number
- NCT00103623
- Locations
- 🇺🇸
Millenium Therapeutics & Research - Urology Practice, Birmingham, Alabama, United States
🇺🇸Valley Urologic Associates, Goodyear, Arizona, United States
🇺🇸Foundation for Cancer Research and Education, Phoenix, Arizona, United States
Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2004-12-30
- Last Posted Date
- 2006-09-19
- Lead Sponsor
- PRAECIS Pharmaceuticals Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00100334
- Locations
- 🇺🇸
Silverado Senior Living, San Juan Capistrano, California, United States
Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors
- Conditions
- Non-Hodgkin's Lymphoma,Solid Tumors
- First Posted Date
- 2004-12-30
- Last Posted Date
- 2007-07-25
- Lead Sponsor
- PRAECIS Pharmaceuticals Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT00100347
- Locations
- 🇺🇸
Universtiy of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2004-12-28
- Last Posted Date
- 2006-09-19
- Lead Sponsor
- PRAECIS Pharmaceuticals Inc.
- Target Recruit Count
- 125
- Registration Number
- NCT00100282
- Locations
- 🇺🇸
Department of Psychiatry & Human Behavior at the University California, Irvine, Orange, California, United States
🇺🇸Global Medical Institutes LLC, Princeton, New Jersey, United States
Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy
- Conditions
- Prostate Cancer
- First Posted Date
- 2004-12-28
- Last Posted Date
- 2006-09-19
- Lead Sponsor
- PRAECIS Pharmaceuticals Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT00100243
- Locations
- 🇺🇸
San Diego Center for Urology, La Mesa, California, United States
🇺🇸Southwest Florida Urological Associates, Fort Myers, Florida, United States
🇺🇸Panama City Urological Center, Panama City, Florida, United States